Evaluation of the effects of type II radical hysterectomy in the treatment of 960 patients with stage IB-IIB cervical carcinoma: A retrospective study

Journal of Surgical Oncology

Volumn 103, Issue 5, 2011, Pages 435-441

  Zheng, Min ^a   Huang, Long ^a   He, Li ^a   Ding, Hui ^a   Wang, Hui Yun ^a   Zheng, Li Min ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Adjuvant therapy; Cervical cancer; Prognostic factors; Radical hysterectomy

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; IFOSFAMIDE; PACLITAXEL;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HAIR LOSS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; OVERALL SURVIVAL; PELVIS LYMPH NODE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; TUMOR RECURRENCE; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; FEASIBILITY STUDIES; FEMALE; HUMANS; HYSTERECTOMY; LYMPHATIC METASTASIS; MIDDLE AGED; MORBIDITY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 79952597712     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21800     Document Type: Article

References (20)

1. Jemal A, Murray T, Ward E, et al.: Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Collins Y, Einstein MH, Gostout BS, et al.: Cervical cancer prevention in the era of prophylactic vaccines: A preview for gynecologic oncologists. Gynecol Oncol 2006;102:552-562. (Pubitemid 44354954)
3. Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
4. Piver MS, Rutledge F, Smith JP: Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974;44:265-272.
5. Querleu D, Morrow CP: Classification of radical hysterectomy. Lancet Oncol 2008;9:297-303.
6. Dueñas-Gonzalez A, Cetina L, Mariscal I, et al.: Modern management of locally advanced cervical carcinoma. Cancer Treat Rev 2003;29:389-399. (Pubitemid 37185105)
7. Chan KK, Naik R: Advances in surgical treatment of cervical cancer. Womens Health (Lond Engl) 2008;4:245-256. (Pubitemid 351781160)
8. Morley GW, Seski JC: Radical pelvic surgery versus radiation therapy for stage 1 carcinoma of the cervix (exclusive of microinvasion). Am J Obstet Gynecol 1976;26:785-794.
9. Hopkins MP, Morley GW: Radical hysterectomy versus radiation therapy for stage IB squamous cell carcinoma of the cervix. Cancer 1991;8:272-277.
10. Landoni F, Maneo A, Colombo A, et al.: Randomised study of radical surgery versus radiotherapy for stage IB-IIA cervical cancer. Lancet 1997;50:535-540. (Pubitemid 27348428)
11. Newton M: Radical hysterectomy or radiotherapy for stage I cervical cancer. A prospective comparison with 5 and 10 years follow-up. Am J Obstet Gynecol 1975;123:535-542.
12. Kasamatsu T, Onda T, Sawada M, et al.: Radical hysterectomy for FIGO stage IIB cervical cancer: Clinicopathological characteristics and prognostic evaluation. Gynecol Oncol 2009;114:69-74.
13. Suprasert P, Srisomboon J, Kasamatsu T: Radical hysterectomy for stage IIB cervical cancer: A review. Int J Gynecol Cancer 2005;15:995-1001. (Pubitemid 43110147)
14. Landoni F, Maneo A, Cormio G, et al.: Class II versus Class III radical hysterectomy in stage IB-IIA cervical cancer: A prospective randomized study. Gynecol Oncol 2001;80:3-12. (Pubitemid 32062080)
15. Pikaart DP, Holloway RW, Ahmad S, et al.: Clinical-pathologic and morbidity analyses of types 2 and 3 abdominal radical hysterectomy for cervical cancer. Gynecol Oncol 2007;107:205-210. (Pubitemid 47575729)
16. Cai HB, Chen HZ, Zhou YF, et al.: Class II radical hysterectomy in low-risk IB squamous cell carcinoma of cervix: A safe and effective option. Int J Gynecol Cancer 2009;19:46-49.
17. Piver MS, Lee JY: The 21st century role of Piver type II hysterectomy in FIGO stage IA, IB cervical cancer: A personal perspective. Eur J Gynaecol Oncol 2008;29:109-113.
18. Kasamatsu T, Onda T, Sawada M, et al.: Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix. Br J Cancer 2009;100:1400-1405.
19. Liu MT, Hsu JC, Liu WS, et al.: Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy. Eur J Cancer Care (Engl) 2008;17:174-181.
20. Shinohara S, Ochi T, Miyazaki T, et al.: Histopathological prognostic factors in patients with cervical cancer treated with radical hysterectomy and postoperative radiotherapy. Int J Clin Oncol 2004;9:503-509.